Bleeding at 57 that looks or feels like a period is uncommon but not rare. The average age of menopause in the United States is 52, with a normal range between 45 and 58. If you haven’t had a period in 12 months or more, any vaginal bleeding is classified as postmenopausal bleeding and needs to be evaluated. If you’re still having occasional periods and haven’t yet gone a full year without one, you may simply be reaching menopause later than average, which is within the normal range. The distinction matters because the cause, and what you should do next, depends on which category you fall into.
Late Perimenopause vs. Postmenopausal Bleeding
Menopause is defined as 12 consecutive months without a period. If you’re 57 and still getting periods every few months, even irregularly, you’re technically still in perimenopause. Some women continue cycling into their late 50s, and while that’s on the later end of normal, it happens. Periods during this phase can be unpredictable: heavier or lighter than usual, closer together or months apart.
If, however, you went a year or more without bleeding and it has now returned, that changes things. This is postmenopausal bleeding, and it always warrants a medical evaluation. Even light spotting counts. The bleeding may turn out to be harmless, but the only way to confirm that is through testing.
The Most Common Causes
The leading cause of postmenopausal bleeding is vaginal and uterine atrophy, responsible for roughly 60% of cases. After menopause, estrogen levels drop sharply, and the tissues lining the vagina and uterus become thinner and more fragile. Blood vessels near the surface can rupture easily, producing spotting or light bleeding that can be mistaken for a period. This type of bleeding is often triggered by physical activity or intercourse, though it can also appear without an obvious cause.
Endometrial polyps account for about 30% of cases. These are small growths on the inner lining of the uterus. In a study of 481 postmenopausal women with polyps found during examination, about half had bleeding and half had no symptoms at all. The vast majority of polyps, over 80% in women with bleeding, are benign. However, roughly 7% of polyps found in women who were bleeding turned out to be cancerous, which is one reason removal and testing is standard.
Endometrial hyperplasia, an overgrowth of the uterine lining, is another possible cause. This happens when the lining is exposed to estrogen without the balancing effect of progesterone. Left untreated, some forms of hyperplasia can progress to cancer over time.
How Body Weight Plays a Role
After menopause, your ovaries stop producing significant estrogen, but your body doesn’t stop making it entirely. Fat tissue becomes the primary source, converting other hormones into estrogen through an enzyme called aromatase. The more fat tissue you carry, the more estrogen your body produces. In women with higher body weight, this ongoing estrogen production can stimulate the uterine lining enough to cause thickening and bleeding, even years after menopause. This is one of the reasons obesity is a well-established risk factor for both endometrial hyperplasia and endometrial cancer.
Bleeding From Hormone Therapy
If you’re taking hormone replacement therapy, breakthrough bleeding is one of the most common side effects. It’s frequently the reason women stop or avoid HRT altogether. Some amount of irregular bleeding in the first several months of a new regimen can be expected, particularly with combined estrogen-progesterone formulas. But what makes postmenopausal women different from younger women on hormones is the higher baseline risk of uterine cancer. Any unscheduled bleeding while on HRT still needs to be properly evaluated rather than assumed to be a side effect.
The Cancer Question
This is likely the concern behind your search, so here are the numbers. A large Danish study tracking over 43,000 women with postmenopausal bleeding found that the absolute risk of endometrial cancer within one year of the bleeding episode was about 4.7%, rising slightly to 5.2% at five years. That means roughly 1 in 20 women with postmenopausal bleeding will be diagnosed with endometrial cancer. Put differently, about 95% of the time, the cause is something else.
Those odds are reassuring but not small enough to ignore. Endometrial cancer caught early, before it spreads beyond the uterus, has an excellent prognosis. The entire point of prompt evaluation is to catch it at that stage.
What Happens During Evaluation
The first step is typically a transvaginal ultrasound, which measures the thickness of your uterine lining. In postmenopausal women, a thin lining (4 millimeters or less) has a greater than 99% negative predictive value for endometrial cancer. In practical terms, if your lining measures 4 mm or under, the chance of cancer is extremely low, around 0.07%.
If the lining is thicker than 4 to 5 millimeters, or if the ultrasound can’t get a clear image, the next step is usually an endometrial biopsy. This is an office procedure using a thin, flexible device inserted through the cervix to collect a small tissue sample. It takes a few minutes, can cause cramping similar to a period, and doesn’t require anesthesia. The tissue is then examined under a microscope to check for abnormal cells.
If the biopsy doesn’t yield enough tissue for a clear diagnosis, or if bleeding continues despite a normal biopsy result, a more detailed procedure called hysteroscopy may follow. This involves a small camera placed inside the uterus, allowing direct visualization of polyps, fibroids, or other abnormalities. Hysteroscopy has a sensitivity of about 83% and specificity above 99% for detecting endometrial cancer, and it’s even more accurate for hyperplasia, with sensitivity reaching 98%.
One important caveat: rare types of endometrial cancer can exist even when the lining appears thin on ultrasound. If bleeding persists or returns after an initial evaluation that looked normal, a tissue biopsy is recommended regardless of what the ultrasound showed.
What to Pay Attention To
Any vaginal bleeding after a confirmed year without periods should be reported to your provider. This includes light pink or brown spotting, a single episode of bright red bleeding, or what feels like a return of your period. The volume and color don’t reliably distinguish between harmless and serious causes.
Keep track of when the bleeding happens, how long it lasts, and whether anything seems to trigger it. If you’re on hormone therapy, note where you are in your regimen cycle. This information helps your provider decide which evaluation pathway makes the most sense for your situation.